Found: 3
Select item for more details and to access through your institution.
A Pilot Study of Apatinib as Third-Line Treatment in Patients With Heavily Treated Metastatic Colorectal Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Safety and efficacy of PD-1 blockade-activated multiple antigen-specific cellular therapy alone or in combination with apatinib in patients with advanced solid tumors: a pooled analysis of two prospective trials.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1467, doi. 10.1007/s00262-019-02375-z
- By:
- Publication type:
- Article
Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2/STAT3/VEGFA signaling in non-small cell lung cancer cells.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1093-3
- By:
- Publication type:
- Article